Hartford Funds Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$903K Sell
37,508
-1,186
-3% -$31K 0.07% 79
2026
Q1
$1.09M Buy
38,694
+2,464
+7% +$65.6K 0.09% 62
2025
Q4
$902K Buy
36,230
+4,599
+15% +$116K 0.07% 70
2025
Q3
$806K Sell
31,631
-2,969
-9% -$73.3K 0.07% 59
2025
Q2
$839K Buy
34,600
+543
+2% +$12.7K 0.07% 62
2025
Q1
$863K Buy
34,057
+4,730
+16% +$124K 0.08% 62
2024
Q4
$778K Sell
29,327
-2,505
-8% -$67.9K 0.07% 56
2024
Q3
$921K Buy
31,832
+1,716
+6% +$50.1K 0.09% 45
2024
Q2
$843K Buy
30,116
+5,696
+23% +$157K 0.08% 45
2024
Q1
$678K Buy
24,420
+2,625
+12% +$72.8K 0.06% 50
2023
Q4
$627K Buy
21,795
+6,086
+39% +$184K 0.06% 45
2023
Q3
$521K Sell
15,709
-6,313
-29% -$223K 0.06% 37
2023
Q2
$808K Buy
22,022
+3,203
+17% +$125K 0.08% 15
2023
Q1
$768K Buy
18,819
+1,584
+9% +$68.4K 0.08% 15
2022
Q4
$883K Buy
17,235
+11,283
+190% +$541K 0.09% 12
2022
Q3
$260K Buy
5,952
+1,642
+38% +$79.8K 0.03% 22
2022
Q2
$226K Buy
+4,310
New +$220K 0.03% 17

Other funds holding PFE

Hartford Funds Management's PFE Position: Q2 2026 in Review

Hartford Funds Management reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $31K and leaving 37,508 shares worth $903K. The position accounts for 0.07% of the portfolio, ranked #79.

Hartford Funds Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.09M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hartford Funds Management held 37,508 shares of Pfizer worth $903K as of Q2 2026.
  • Hartford Funds Management sold 1,186 Pfizer shares in Q2 2026, an estimated $31K.
  • Pfizer made up 0.07% of Hartford Funds Management's portfolio in Q2 2026, its #79 holding.
  • Hartford Funds Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Hartford Funds Management's Pfizer position peaked at $1.09M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hartford Funds Management's 13F filing for Q2 2026, filed 6 Aug 2026.